Market Overview

JPMorgan CEO Jamie Dimon Seeks Treatment For Throat Cancer

JPMorgan CEO Jamie Dimon Seeks Treatment For Throat Cancer
Related JPM
JPMorgan Embraces's Fintech Tools
Todd Gordon's JPMorgan Options Trade
US Market Indexes Lower on Thursday (GuruFocus)

Jamie Dimon, Chief Executive Officer of JPMorgan Chase (NYSE: JPM) since 2005, announced on Tuesday that he has been diagnosed with throat cancer.

The condition is said to be curable, according to a memo sent to the company's employees and shareholders.

Dimon said he plans to continue to take part in key decisions while receiving an eight-week treatment plan at Memorial Sloan Kettering Hospital in New York. The treatment will include radiation and chemotherapy, which, according to the hospital's website, is the "standard curative treatment" for a large number of individuals with the condition.

Related: Rick Snyder And Mike Duggan Stand Behind JP Morgan's Commitment To Detroit

"I feel very good now," said Dimon, adding that he will keep everyone updated on any changes in his health.

Shares of JPMorgan Chase were trading down about 0.52 percent in Wednesday's pre-market.

Dimon recently visited Detroit to bring a $100 million investment to the beleaguered city.

“This is the first time JPMorgan Chase has came into a town, met with leadership and said, 'What can we do to help,'" stated Dimon back in May. The goal is to help multiple city measures, as the $100 million will be spread out over various concerns.

Posted-In: Jamie DimonNews Management Best of Benzinga


Related Articles (JPM)

View Comments and Join the Discussion!